Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 31 peer-reviewed journal articles Updated
Cardiology · Myocarditis

How Are Myocarditis and Takotsubo Unlike a Heart Attack?

At a Glance

Myocarditis and Takotsubo syndrome can mimic a heart attack with similar chest pain, ECG changes, and rises in a blood marker called troponin. Doctors combine coronary angiography, echocardiography, and heart MRI to check for artery blockages and identify the pattern of heart-muscle injury.

It is frightening to be rushed to the hospital with severe chest pain and be told you might be having a heart attack. When you arrive with these symptoms, the emergency team will treat you for a heart attack (acute myocardial infarction) until proven otherwise [1][2].

However, two conditions—myocarditis (inflammation of the heart muscle) and Takotsubo syndrome (a temporary stress-induced heart dysfunction)—can perfectly mimic a heart attack [3]. Doctors distinguish between these conditions by looking at your blood vessels and identifying the specific pattern of injury in your heart muscle [4].

The Initial Overlap: Why They Look Alike

In the emergency room, it is nearly impossible to tell these conditions apart:

  • Symptoms: All three can cause severe chest pain, shortness of breath, and fainting [3].
  • Troponin Levels: Troponin is a protein released when heart muscle is damaged. While a heart attack might cause higher troponin levels on average, all three conditions cause a rise in troponin that proves the heart is injured [5][6].
  • ECG (Electrocardiogram): The electrical patterns, including ST-segment elevation, overlap heavily and can look very similar across all three conditions [7].

The Decisive Tests

Because the initial tests overlap, doctors rely on advanced imaging. It is important to know that a clear angiogram does not automatically mean you didn’t have a heart attack. A condition called MINOCA (Myocardial Infarction with Non-Obstructed Coronary Arteries) can happen if a blood clot dissolves, an artery spasms, or a vessel tears [8]. Therefore, doctors use these tests together:

  • Coronary Angiography: A catheter is threaded to the heart to look for blockages. Many classic heart attacks show a ruptured plaque and a blood clot [8]. In myocarditis and Takotsubo syndrome, the arteries are often unobstructed, though they can sometimes coexist with underlying coronary artery disease [9][10].
  • Echocardiography (Echo): This heart ultrasound looks at how the muscle squeezes. A heart attack usually weakens an area supplied by one specific blocked artery. In Takotsubo syndrome, the abnormal movement often extends beyond a single artery’s territory, sometimes creating a unique “ballooning” shape at the bottom or middle of the heart [11][12].
  • Cardiac MRI (CMR): If the angiogram does not show a clear culprit blockage, a cardiac MRI helps clarify the diagnosis [4]. It looks for tissue swelling (edema) and a pattern of injury or fibrosis called late gadolinium enhancement (LGE):
    • Heart Attack: Injury typically starts from the inner lining of the heart wall (subendocardial) or goes all the way through the muscle (transmural) [13][14].
    • Myocarditis: Injury and inflammation usually appear on the outer layer (subepicardial) or the middle of the heart wall [13][15].
    • Takotsubo Syndrome: The MRI typically shows swelling (edema) but little to no permanent injury pattern (LGE) [13][16].

Condition Comparison

Feature Heart Attack (Infarction) Myocarditis Takotsubo Syndrome
Likely Cause Blocked or damaged artery Viral infection, autoimmune Physical or emotional stress
Angiogram Often shows blockage or plaque Usually open arteries Usually open arteries
MRI Pattern Inner wall / Full thickness injury Outer / Middle wall injury Swelling (edema) without major permanent injury
Treatment Focus Opening artery, Antiplatelets Rest, rhythm monitoring, treating inflammation Managing acute complications, removing stressors

How Treatment Differs

🛑 MEDICATION SAFETY WARNING
Never stop or change your prescribed medications without explicit instructions from your cardiology team.

  • Antiplatelets (like aspirin, clopidogrel, ticagrelor) prevent platelets from sticking together to form clots, especially in stents. Stopping them too early can cause a fatal clot.
  • Anticoagulants (like warfarin, apixaban, DOACs) slow down the body’s entire clotting process.
    Always ask your doctor exactly which medications you are taking, what they are for, and how long you must take them.

Treating a Heart Attack
Many heart attacks caused by an obstructed artery are treated with a procedure called PCI (placing a stent to hold the artery open) [17]. Patients are usually prescribed dual antiplatelet therapy (DAPT)—aspirin plus a second antiplatelet—for an individualized duration based on their stent type, medical guidelines, and bleeding risk [17][2].

Treating Myocarditis
Because myocarditis does not involve a ruptured plaque, stents and routine heart-attack antiplatelets are generally not needed unless you also have coronary artery disease [18]. Treatment focuses on letting the inflamed heart rest:

  • Rest and Restriction: You will likely be instructed to strictly avoid sports and strenuous exercise. A common framework is 3 to 6 months, but this is highly individualized based on your symptoms and recovery. A repeat MRI or other tests will be used by your doctor to clear you to safely return to activity [19][20].
  • Rhythm Monitoring: Inflammation can irritate the heart’s electrical system. You may be monitored continuously on telemetry in the hospital, and given an ambulatory monitor (like a Holter) for home use [21][22].
  • Heart Failure Medications: If your heart’s pumping ability is reduced, guideline-directed heart failure medications (such as beta-blockers or ACE inhibitors) may be prescribed if appropriate for your blood pressure and kidney function [23].
  • Immune Suppression: For specific, rare forms of myocarditis (like giant-cell or autoimmune), specialists may use medications to suppress the immune system [23][24].

Treating Takotsubo Syndrome
Also known as “broken heart syndrome,” Takotsubo is often triggered by severe physical illness or emotional stress, though a trigger isn’t always found (do not blame yourself if you cannot identify one). The heart muscle is stunned, but usually recovers within 6 to 12 weeks with individualized care [25].

  • Managing Acute Complications: The initial phase is managed closely by specialists in the hospital [26]. Some patients develop LV outflow-tract obstruction, where the ballooning heart muscle temporarily blocks blood from exiting. Specialists manage this carefully with fluids and specific medications (like short-acting beta-blockers) while avoiding stimulating drugs (inotropes) [27][28]. Do not attempt to manage your fluid intake or adjust medications on your own.
  • Anticoagulation (Blood Thinners): If the ballooning is severe or your pumping function is very low, your doctor might prescribe short-term oral anticoagulants (usually for about 3 months) to prevent a clot from forming in the heart, or to treat one if it has already formed [29][30]. Follow-up echocardiograms will monitor your recovery [31].

When to Seek Emergency Help

After discharge, do not assume new symptoms are just stress or a normal part of recovery. Call 911 or go to the emergency room immediately if you experience:

  • New or worsening chest pain or pressure
  • Fainting or severe dizziness
  • Severe or sudden shortness of breath
  • Sustained, rapid heart palpitations

Common questions in this guide

Can myocarditis or Takotsubo syndrome feel like a heart attack?
Yes. Both can cause chest pain, shortness of breath, fainting, ECG changes, and a rise in troponin, a blood marker of heart-muscle injury. Doctors need imaging and other tests to tell which condition is causing the symptoms.
Does a normal coronary angiogram rule out a heart attack?
No. A heart attack can occur even when the major coronary arteries look open, a situation called MINOCA, because a clot may dissolve or an artery may spasm or tear. Doctors combine the angiogram with echocardiography and cardiac MRI to identify the cause.
What does cardiac MRI show in myocarditis, Takotsubo syndrome, and a heart attack?
In a heart attack, MRI usually shows injury starting in the inner part of the heart wall or extending through its full thickness. Myocarditis more often affects the outer or middle wall, while Takotsubo syndrome usually shows swelling with little or no lasting injury pattern. Your cardiology team interprets these findings with your other tests.
How is Takotsubo syndrome different from a heart attack?
Takotsubo syndrome is a temporary stress-related weakening of the heart that often occurs with open coronary arteries. The weakened area can extend beyond the territory of one artery, and heart function often improves within 6 to 12 weeks. It can still be serious and needs hospital monitoring and follow-up.
Do myocarditis and Takotsubo syndrome require the same medicines as a heart attack?
Not necessarily. A blocked-artery heart attack may require a stent and antiplatelet medicines, while myocarditis usually focuses on rest, rhythm monitoring, and treatment of reduced heart function; Takotsubo treatment is tailored to complications and recovery. Do not stop or change an antiplatelet, anticoagulant, or heart-failure medicine without instructions from your cardiology team.
When can I exercise again after myocarditis?
Return to exercise is individualized and often involves avoiding strenuous activity for about 3 to 6 months. Your doctor may use symptoms, heart monitoring, repeat imaging, or other tests before clearing you. Do not resume intense exercise without medical clearance.
How long does Takotsubo syndrome take to recover?
Heart function often improves within 6 to 12 weeks, but recovery varies and some people develop complications such as a clot or an abnormal heart rhythm. Follow-up echocardiograms and cardiology visits help confirm recovery and guide medicines. Seek emergency help for new chest pain, fainting, severe shortness of breath, or sustained rapid palpitations.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Related questions

Heart Attack Fatigue: How Long and When Is Activity Safe? How Long Can Troponin Stay High After a Heart Attack? Missed Antiplatelet Dose After a Heart Attack or Stent? Is Bruising Normal on Dual Antiplatelet Therapy After MI? What Happens After a MINOCA Heart Attack Diagnosis?
Show more
How Do I Care for My Catheter Site After an Angiogram? Should I Chew Aspirin for a Suspected Heart Attack? Are Palpitations After a Heart Attack Dangerous? Monitoring When Is an ICD Considered After a Heart Attack with Low EF? What Are Heart Failure Warning Signs After a Heart Attack? What Does LVEF Mean After a Heart Attack? Explained How Are Mental Health Symptoms Treated After a Heart Attack? How Do I Prevent Stent Thrombosis and Restenosis After MI? Does Type 2 MI Need a Stent or the Same Medications? What Is SCAD and How Is a SCAD Heart Attack Treated? Why Are Heparin and Antiplatelets Both Used in PCI? Why Was I Given a Stent or Clot-Buster for My Heart Attack? What Happens During a Coronary Angiogram and Stent? What Mechanical Complications Follow a Heart Attack?

Get notified when new evidence is published on acute myocardial infarction.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Did my coronary angiogram show any signs of a treatable blockage, or does my clinical picture suggest MINOCA, myocarditis, or Takotsubo syndrome?
  2. 2.Based on my echocardiogram and cardiac MRI, what is the specific pattern of my heart muscle injury?
  3. 3.If my diagnosis is myocarditis, what is my individualized timeline for returning to exercise, and what specific tests will we use to clear me?
  4. 4.If I have Takotsubo syndrome, will I need a follow-up echocardiogram to confirm my heart function has fully recovered, and do I need temporary anticoagulants?
  5. 5.Which of the medications I was started on in the emergency room (such as antiplatelets, anticoagulants, or heart-failure medicines) should I continue, and for exactly how long?

References

References (31)
  1. 1

    An Extensive Review on Imaging Diagnosis Methods in Takotsubo Syndrome.

    Paraschiv C, Paduraru L, Balanescu S

    Reviews in cardiovascular medicine 2023; (24(10)):300 doi:10.31083/j.rcm2410300.

    PMID: 39077560
  2. 2

    Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy.

    Babes EE, Bustea C, Behl T, et al.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022; (148()):112772 doi:10.1016/j.biopha.2022.112772.

    PMID: 35245735
  3. 3

    Case report: acute myocarditis in two patients with coronary artery disease presenting with chest pain-thinking outside the box.

    Amelotti N, Brusamolino M, Mapelli M, et al.

    European heart journal. Case reports 2024; (8(5)):ytae220 doi:10.1093/ehjcr/ytae220.

    PMID: 38736997
  4. 4

    Diagnostic contribution of cardiac magnetic resonance in patients with acute coronary syndrome and culprit-free angiograms.

    Kawecki D, Morawiec B, Monney P, et al.

    Medical science monitor : international medical journal of experimental and clinical research 2015; (21()):171-80 doi:10.12659/MSM.892296.

    PMID: 25604184
  5. 5

    High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain.

    Sandoval Y, Apple FS, Mahler SA, et al.

    Circulation 2022; (146(7)):569-581 doi:10.1161/CIRCULATIONAHA.122.059678.

    PMID: 35775423
  6. 6

    Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction.

    Wereski R, Kimenai DM, Taggart C, et al.

    Circulation 2021; (144(7)):528-538 doi:10.1161/CIRCULATIONAHA.121.054302.

    PMID: 34167318
  7. 7

    Cardiac magnetic resonance assessment of takotsubo cardiomyopathy.

    Abbas A, Sonnex E, Pereira RS, Coulden RA

    Clinical radiology 2016; (71(1)):e110-9.

    PMID: 26607916
  8. 8

    Association between Inflammation and New-Onset Atrial Fibrillation in Acute Coronary Syndromes.

    Băghină RM, Crișan S, Luca S, et al.

    Journal of clinical medicine 2024; (13(17)) doi:10.3390/jcm13175088.

    PMID: 39274304
  9. 9

    Additional diagnostic value of CMR to the European Society of Cardiology (ESC) position statement criteria in a large clinical population of patients with suspected myocarditis.

    Biesbroek PS, Hirsch A, Zweerink A, et al.

    European heart journal. Cardiovascular Imaging 2018; (19(12)):1397-1407 doi:10.1093/ehjci/jex308.

    PMID: 29186442
  10. 10

    Takotsubo Syndrome Triggered by Acute Myocardial Infarction.

    González Alirangues P, Artiaga de la Barrera V, García Jiménez C, Ortiz Cortés C

    Cureus 2024; (16(9)):e70417 doi:10.7759/cureus.70417.

    PMID: 39473676
  11. 11

    Advanced cardiac magnetic resonance imaging in takotsubo cardiomyopathy.

    Ojha V, Khurana R, Ganga KP, Kumar S

    The British journal of radiology 2020; (93(1115)):20200514 doi:10.1259/bjr.20200514.

    PMID: 32795180
  12. 12

    Epidemiology, pathogenesis, and management of takotsubo syndrome.

    Y-Hassan S, Tornvall P

    Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2018; (28(1)):53-65 doi:10.1007/s10286-017-0465-z.

    PMID: 28917022
  13. 13

    [Cardiac magnetic resonance imaging in patients with a suspected myocardial infarction and normal coronary arteries].

    Díaz-Navarro R, Silva González D, Henríquez-Roldán C

    Revista medica de Chile 2020; (148(10)):1406-1417 doi:10.4067/S0034-98872020001001406.

    PMID: 33844710
  14. 14

    [Cardiac magnetic resonance imaging for the diagnosis of acute myocarditis mimicking a myocardial infarction].

    Díaz-Navarro R, Pepe RV, Silva González D

    Revista medica de Chile 2021; (149(10)):1399-1411 doi:10.4067/s0034-98872021001001399.

    PMID: 35319629
  15. 15

    Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations.

    Ferreira VM, Schulz-Menger J, Holmvang G, et al.

    Journal of the American College of Cardiology 2018; (72(24)):3158-3176 doi:10.1016/j.jacc.2018.09.072.

    PMID: 30545455
  16. 16

    MRI findings in patients with acute coronary syndrome and unobstructed coronary arteries.

    Abanador-Kamper N, Kamper L, Castello-Boerrigter L, et al.

    Diagnostic and interventional radiology (Ankara, Turkey) 2019; (25(1)):28-34 doi:10.5152/dir.2018.18004.

    PMID: 30582569
  17. 17

    Acute coronary syndromes.

    Bergmark BA, Mathenge N, Merlini PA, et al.

    Lancet (London, England) 2022; (399(10332)):1347-1358 doi:10.1016/S0140-6736(21)02391-6.

    PMID: 35367005
  18. 18

    Management of acute myocarditis: a systematic review of clinical practice guidelines and recommendations.

    Shyam-Sundar V, Mahmood A, Slabaugh G, et al.

    European heart journal. Quality of care & clinical outcomes 2024; (10(8)):658-668 doi:10.1093/ehjqcco/qcae069.

    PMID: 39179417
  19. 19

    Myocarditis in athletes: A clinical perspective.

    Halle M, Binzenhöfer L, Mahrholdt H, et al.

    European journal of preventive cardiology 2021; (28(10)):1050-1057 doi:10.1177/2047487320909670.

    PMID: 33611403
  20. 20

    2020 ESC Guidelines on Sports Cardiology: Impact of CMR Criteria on Return-to-Play Clearance After Acute Myocarditis.

    Gallinoro CM, Scatteia A, Catapano D, et al.

    Journal of cardiovascular development and disease 2025; (12(12)) doi:10.3390/jcdd12120469.

    PMID: 41440847
  21. 21

    Life-threatening arrhythmia in patients with suspected acute myocarditis.

    Krempke M, Büchel J, Bulatova K, et al.

    International journal of cardiology. Heart & vasculature 2025; (59()):101718 doi:10.1016/j.ijcha.2025.101718.

    PMID: 40606202
  22. 22

    Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society.

    Peretto G, Basso C, Berruezo A, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2026; (28(8)) doi:10.1093/europace/euag153.

    PMID: 42669046
  23. 23

    Diagnosis and Treatment of Acute Myocarditis: A Review.

    Ammirati E, Moslehi JJ

    JAMA 2023; (329(13)):1098-1113 doi:10.1001/jama.2023.3371.

    PMID: 37014337
  24. 24

    Viral presence-guided immunomodulation in lymphocytic myocarditis: an update.

    Sinagra G, Porcari A, Gentile P, et al.

    European journal of heart failure 2021; (23(2)):211-216 doi:10.1002/ejhf.1969.

    PMID: 32683758
  25. 25

    Takotsubo syndrome.

    Gupta S, Gupta MM

    Indian heart journal 2018; (70(1)):165-174 doi:10.1016/j.ihj.2017.09.005.

    PMID: 29455773
  26. 26

    Takotsubo Syndrome and Sudden Cardiac Death.

    Manolis AA, Manolis TA, Melita H, Manolis AS

    Angiology 2023; (74(2)):105-128 doi:10.1177/00033197221105757.

    PMID: 35668627
  27. 27

    Dynamic Left Intraventricular Obstruction Phenotype in Takotsubo Syndrome.

    Di Vece D, Silverio A, Bellino M, et al.

    Journal of clinical medicine 2021; (10(15)) doi:10.3390/jcm10153235.

    PMID: 34362020
  28. 28

    Hemodynamic Effects, Safety, and Feasibility of Intravenous Esmolol Infusion During Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction: Results From A Multicenter Registry.

    Santoro F, Ieva R, Ferraretti A, et al.

    Cardiovascular therapeutics 2016; (34(3)):161-6 doi:10.1111/1755-5922.12182.

    PMID: 26946520
  29. 29

    Left Ventricular Thrombi in Takotsubo Syndrome: Incidence, Predictors, and Management: Results From the GEIST (German Italian Stress Cardiomyopathy) Registry.

    Santoro F, Stiermaier T, Tarantino N, et al.

    Journal of the American Heart Association 2017; (6(12)) doi:10.1161/JAHA.117.006990.

    PMID: 29203578
  30. 30

    Epidemiology, Pathophysiology, Diagnosis, and Principles of Management of Takotsubo Cardiomyopathy: A Review.

    Matta AG, Carrié D

    Medical science monitor : international medical journal of experimental and clinical research 2023; (29()):e939020 doi:10.12659/MSM.939020.

    PMID: 36872594
  31. 31

    Takotsubo Cardiomyopathy: Patients Characteristics, Mortality, and Clinical Significance of Left Ventricular Outflow Tract Gradient, Retrospective Study.

    Daralammouri Y, Hamayel H, Abugaber D, Nabulsi S

    Cardiology research and practice 2024; (2024()):5549795 doi:10.1155/2024/5549795.

    PMID: 39015408

This page is for informational purposes only and does not constitute medical advice. It explains how clinicians compare myocarditis, Takotsubo syndrome, and heart attack; new or worsening chest pain requires emergency evaluation.